RECRUITING
I'm interested ...!!
Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation
Demonstrate the impact of the Molecular Microscope Diagnostic System as the standard of care for heart transplant patients.
Conditions:
🦠 Cardiac Transplant Disorder
🗓️ Study Start (Actual) January 2016
🗓️ Primary Completion (Estimated) December 2024
✅ Study Completion (Estimated) July 2025
👥 Enrollment (Estimated) 900
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 Los Angeles, California, United States
📍 Los Angeles, California, United States
📍 Salt Lake City, Utah, United States
📍 Richmond, Virginia, United States
📍 Darlinghurst, Australia
📍 Vienna, Austria
📍 Edmonton, Alberta, Canada
📍 Edmonton, Alberta, Canada
📍 Paris, France
📍 Bologna, Italy
📍 La Coruna, Spain
More locations available...

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * biopsy for clinical indications

    Exclusion Criteria:

    • * no consent
    • * pregnant women
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 22 January 2016
  • First Submitted that Met QC Criteria 27 January 2016
  • First Posted 1 February 2016

Study Record Updates

  • Last Update Submitted that Met QC Criteria 3 June 2024
  • Last Update Posted 5 June 2024
  • Last Verified June 2024
I'm interested ...!!